Evidence map›Paper›PMID 40989332›Full record

ArticlePeerJ. Computer science2025

Improving machine learning detection of Alzheimer disease using enhanced manta ray gene selection of Alzheimer gene expression datasets.

Zahraa Ahmed, Mesut Çevik

Abstract read
In one paragraph

Article in PeerJ. Computer science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Zahraa AhmedDepartment of Electrical and Computer Engineering, Altınbaş Üniversitesi, Istanbul, Turkey.
Mesut ÇevikDepartment of Electrical and Computer Engineering, Altınbaş Üniversitesi, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the most prominent neurodegenerative diseases globally is Alzheimer's disease (AD). The early diagnosis of AD is a challenging task due to complex pathophysiology caused by the presence and accumulation of neurofibrillary tangles and amyloid plaques. However, the late enriched understanding of the genetic underpinnings of AD has been made possible due to recent advancements in data mining analysis methods, machine learning, and microarray technologies. However, the "curse of dimensionality" caused by the high-dimensional microarray datasets impacts the accurate prediction of the disease due to issues of overfitting, bias, and high computational demands. To alleviate such an effect, this study proposes a gene selection approach based on the parameter-free and large-scale manta ray foraging optimization algorithm. Given the dimensional disparities and statistical relationship distributions of the six investigated datasets, in addition to four evaluated machine learning classifiers; the proposed Sign Random Mutation and Best Rank enhancements that substantially improved MRFO's exploration and exploitation contributed to efficient identification of relevant genes and to machine learning improved prediction accuracy.

Indexed as

Alzheimer’s diseaseBest rankDimensionality reductionGene selectionManta ray foraging optimizer (MRFO)Sign random mutation

Identifiers

PMID40989332
PMCPMC12453835

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.